161 related articles for article (PubMed ID: 7883122)
1. Analysis of the hexokinase II gene in subjects with insulin resistance and NIDDM and detection of a Gln142-->His substitution.
Vidal-Puig A; Printz RL; Stratton IM; Granner DK; Moller DE
Diabetes; 1995 Mar; 44(3):340-6. PubMed ID: 7883122
[TBL] [Abstract][Full Text] [Related]
2. Variant sequences of the Hexokinase II gene in familial NIDDM.
Taylor RW; Printz RL; Armstrong M; Granner DK; Alberti KG; Turnbull DM; Walker M
Diabetologia; 1996 Mar; 39(3):322-8. PubMed ID: 8721778
[TBL] [Abstract][Full Text] [Related]
3. Human hexokinase II gene: exon-intron organization, mutation screening in NIDDM, and its relationship to muscle hexokinase activity.
Lehto M; Huang X; Davis EM; Le Beau MM; Laurila E; Eriksson KF; Bell GI; Groop L
Diabetologia; 1995 Dec; 38(12):1466-74. PubMed ID: 8786021
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of the human hexokinase II gene: lack of association with NIDDM and insulin resistance.
Laakso M; Malkki M; Kekäläinen P; Kuusisto J; Deeb SS
Diabetologia; 1995 May; 38(5):617-22. PubMed ID: 7489847
[TBL] [Abstract][Full Text] [Related]
5. Identification of four amino acid substitutions in hexokinase II and studies of relationships to NIDDM, glucose effectiveness, and insulin sensitivity.
Echwald SM; Bjørbaek C; Hansen T; Clausen JO; Vestergaard H; Zierath JR; Printz RL; Granner DK; Pedersen O
Diabetes; 1995 Mar; 44(3):347-53. PubMed ID: 7883123
[TBL] [Abstract][Full Text] [Related]
6. Amino acid substitutions in hexokinase II among patients with NIDDM.
Laakso M; Malkki M; Deeb SS
Diabetes; 1995 Mar; 44(3):330-4. PubMed ID: 7883120
[TBL] [Abstract][Full Text] [Related]
7. Molecular scanning of insulin-responsive glucose transporter (GLUT4) gene in NIDDM subjects.
Choi WH; O'Rahilly S; Buse JB; Rees A; Morgan R; Flier JS; Moller DE
Diabetes; 1991 Dec; 40(12):1712-8. PubMed ID: 1756912
[TBL] [Abstract][Full Text] [Related]
8. Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients.
Vestergaard H; Bjørbaek C; Hansen T; Larsen FS; Granner DK; Pedersen O
J Clin Invest; 1995 Dec; 96(6):2639-45. PubMed ID: 8675629
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance.
Moller DE; Cohen O; Yamaguchi Y; Assiz R; Grigorescu F; Eberle A; Morrow LA; Moses AC; Flier JS
Diabetes; 1994 Feb; 43(2):247-55. PubMed ID: 8288049
[TBL] [Abstract][Full Text] [Related]
10. Detection of mutations in insulin-receptor gene in NIDDM patients by analysis of single-stranded conformation polymorphisms.
O'Rahilly S; Choi WH; Patel P; Turner RC; Flier JS; Moller DE
Diabetes; 1991 Jun; 40(6):777-82. PubMed ID: 2040394
[TBL] [Abstract][Full Text] [Related]
11. Variability of the insulin gene in American blacks with NIDDM. Analysis by single-strand conformational polymorphisms.
Olansky L; Janssen R; Welling C; Permutt MA
Diabetes; 1992 Jun; 41(6):742-9. PubMed ID: 1350258
[TBL] [Abstract][Full Text] [Related]
12. HepG2/erythrocyte glucose transporter (GLUT1) gene in NIDDM: a population association study and molecular scanning in Japanese subjects.
Tao T; Tanizawa Y; Matsutani A; Matsubara A; Kaneko T; Kaku K
Diabetologia; 1995 Aug; 38(8):942-7. PubMed ID: 7589880
[TBL] [Abstract][Full Text] [Related]
13. Genetic analysis of the insulin receptor gene in Chinese patients with extreme insulin resistance.
Lee WJ; Sheu WH; Shu SG; Yao YE
Zhonghua Yi Xue Za Zhi (Taipei); 1998 Nov; 61(11):636-42. PubMed ID: 9872020
[TBL] [Abstract][Full Text] [Related]
14. Molecular scanning of the insulin receptor substrate-1 (IRS-1) gene in Japanese patients with NIDDM: identification of five novel polymorphisms.
Ura S; Araki E; Kishikawa H; Shirotani T; Todaka M; Isami S; Shimoda S; Yoshimura R; Matsuda K; Motoyoshi S; Miyamura N; Kahn CR; Shichiri M
Diabetologia; 1996 May; 39(5):600-8. PubMed ID: 8739921
[TBL] [Abstract][Full Text] [Related]
15. Variability of the pancreatic islet beta cell/liver (GLUT 2) glucose transporter gene in NIDDM patients.
Tanizawa Y; Riggs AC; Chiu KC; Janssen RC; Bell DS; Go RP; Roseman JM; Acton RT; Permutt MA
Diabetologia; 1994 Apr; 37(4):420-7. PubMed ID: 8063045
[TBL] [Abstract][Full Text] [Related]
16. UKPDS 19: heterogeneity in NIDDM: separate contributions of IRS-1 and beta 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. UK Prospective Diabetes Study.
Zhang Y; Wat N; Stratton IM; Warren-Perry MG; Orho M; Groop L; Turner RC
Diabetologia; 1996 Dec; 39(12):1505-11. PubMed ID: 8960833
[TBL] [Abstract][Full Text] [Related]
17. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
Pendergrass M; Koval J; Vogt C; Yki-Jarvinen H; Iozzo P; Pipek R; Ardehali H; Printz R; Granner D; DeFronzo RA; Mandarino LJ
Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744
[TBL] [Abstract][Full Text] [Related]
18. Methionine for valine substitution in exon 17 of the insulin receptor gene in a pedigree with familial NIDDM.
Elbein SC; Sorensen LK; Schumacher MC
Diabetes; 1993 Mar; 42(3):429-34. PubMed ID: 8432414
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of the human muscle glycogen synthase gene.
Orho M; Nikula-Ijäs P; Schalin-Jäntti C; Permutt MA; Groop LC
Diabetes; 1995 Sep; 44(9):1099-105. PubMed ID: 7657035
[TBL] [Abstract][Full Text] [Related]
20. High frequency of polymorphism but no mutations found in the GLUT1 glucose transporter gene in NIDDM and familial obesity by SSCP analysis.
Baroni MG; D'Andrea MP; Capici F; Buzzetti R; Cavallo MG; Fallucca F; Giovannini C; Pozzilli P
Hum Genet; 1998 Apr; 102(4):479-82. PubMed ID: 9600248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
